Safety and long-term efficacy of repeated dexamethasone intravitreal implant for the treatment of cystoid macular edema secondary to retinal vein occlusion with and without a switch to anti-VEGF agents: a 3-year experience.

Suppr

超能文献

作者信息

Călugăru Dan, Călugăru Mihai

机构信息

Department of Ophthalmology, University of Medicine Cluj-Napoca/Romania, Cluj-Napoca, Romania.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2018 Nov;256(11):2269-2270. doi: 10.1007/s00417-018-4094-6. Epub 2018 Aug 2.

DOI:10.1007/s00417-018-4094-6

PMID:30069751

Abstract

摘要

相似文献

Safety and long-term efficacy of repeated dexamethasone intravitreal implant for the treatment of cystoid macular edema secondary to retinal vein occlusion with and without a switch to anti-VEGF agents: a 3-year experience.

Graefes Arch Clin Exp Ophthalmol. 2018 Nov;256(11):2269-2270. doi: 10.1007/s00417-018-4094-6. Epub 2018 Aug 2.

Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.重复玻璃体内注射地塞米松治疗视网膜静脉阻塞继发的黄斑囊样水肿（无论是否转换为抗血管内皮生长因子药物）的安全性和长期疗效：一项为期3年的经验

Graefes Arch Clin Exp Ophthalmol. 2018 Aug;256(8):1441-1448. doi: 10.1007/s00417-018-4016-7. Epub 2018 May 31.

Response to safety and long-term efficacy of repeated dexamethasone intravitreal implant for the treatment of cystoid macular edema secondary to retinal vein occlusion with and without a switch to anti-VEGF agents: a 3-year experience.

Graefes Arch Clin Exp Ophthalmol. 2018 Nov;256(11):2271. doi: 10.1007/s00417-018-4095-5.

SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.玻璃体内注射Ozurdex®治疗视网膜静脉阻塞合并黄斑囊样水肿的频域光学相干断层扫描图像特征

Eur J Ophthalmol. 2011 Sep-Oct;21(5):631-6. doi: 10.5301/EJO.2011.7428.

Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting.玻璃体内注射地塞米松植入物用于临床治疗视网膜静脉阻塞后的黄斑水肿。

Klin Monbl Augenheilkd. 2013 Apr;230(4):423-6. doi: 10.1055/s-0032-1328388. Epub 2013 Apr 29.

Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.在法国临床环境中，地塞米松玻璃体内植入物用于治疗视网膜静脉阻塞继发黄斑水肿的两年前瞻性多中心研究。

Graefes Arch Clin Exp Ophthalmol. 2016 Dec;254(12):2307-2318. doi: 10.1007/s00417-016-3394-y. Epub 2016 Jun 11.

Intravitreal dexamethasone implant versus anti-VEGF injection for treatment-naïve patients with retinal vein occlusion and macular edema: a 12-month follow-up study.玻璃体内注射地塞米松植入物与抗血管内皮生长因子注射治疗初治视网膜静脉阻塞合并黄斑水肿患者的12个月随访研究。

Graefes Arch Clin Exp Ophthalmol. 2015 Dec;253(12):2095-102. doi: 10.1007/s00417-015-2947-9. Epub 2015 Feb 12.

Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment.视网膜静脉阻塞以及地塞米松玻璃体内植入物（Ozurdex®）在其治疗中的应用。

Graefes Arch Clin Exp Ophthalmol. 2016 Jul;254(7):1257-65. doi: 10.1007/s00417-016-3350-x. Epub 2016 May 13.

Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.玻璃体内注射贝伐单抗后再行地塞米松植入与地塞米松植入单药治疗视网膜静脉阻塞伴黄斑水肿的比较。

Ophthalmologica. 2012;228(2):110-6. doi: 10.1159/000338732. Epub 2012 Jun 23.

Recalcitrant macular edema after intravitreal bevacizumab is responsive to an intravitreal dexamethasone implant in retinal vein occlusion.玻璃体内注射贝伐单抗后顽固的黄斑水肿对视网膜静脉阻塞的玻璃体内地塞米松植入物有反应。

Retina. 2013 Jun;33(6):1227-31. doi: 10.1097/IAE.0b013e31827c53a0.

引用本文的文献

Romanian ophthalmologists in the renowned ophthalmic journals worldwide.罗马尼亚眼科医生发表于全球知名眼科期刊上的文章。（原英文表述不太完整准确，推测完整意思应该是类似这样，若按照字面翻译是：罗马尼亚眼科医生在全球著名眼科期刊里）

Rom J Ophthalmol. 2018 Oct-Dec;62(4):260-269.

本文引用的文献

Graefes Arch Clin Exp Ophthalmol. 2018 Aug;256(8):1441-1448. doi: 10.1007/s00417-018-4016-7. Epub 2018 May 31.

Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study.地塞米松玻璃体内植入物治疗中国患者视网膜静脉阻塞继发黄斑水肿的安全性和有效性：随机、假手术对照、多中心研究

Graefes Arch Clin Exp Ophthalmol. 2018 Jun;256(6):1209-1210. doi: 10.1007/s00417-018-3918-8. Epub 2018 Feb 4.

Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion.视网膜内层结构紊乱作为静脉阻塞继发黄斑水肿患者视力的预测指标

Am J Ophthalmol. 2017 Dec;184:190-191. doi: 10.1016/j.ajo.2017.09.019. Epub 2017 Oct 9.

Comment on "Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion".关于“玻璃体内注射贝伐单抗治疗视网膜中央静脉阻塞所致黄斑水肿后中央子区域黄斑中心凹厚度短期预后的预测因素”的评论

Int J Ophthalmol. 2017 Sep 18;10(9):1481-1482. doi: 10.18240/ijo.2017.09.25. eCollection 2017.

Comments to: Real-World Outcomes of Anti-VEGF Treatment for Retinal Vein Occlusion in Portugal.致《葡萄牙视网膜静脉阻塞抗VEGF治疗的真实世界结果》的评论

Eur J Ophthalmol. 2017 Nov 8;27(6):e190-e191. doi: 10.5301/ejo.5001016.

Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.美国雷珠单抗玻璃体内注射和地塞米松玻璃体内植入治疗视网膜静脉阻塞的治疗模式

Eye (Lond). 2017 Jul;31(7):1112-1113. doi: 10.1038/eye.2017.12. Epub 2017 Mar 17.

Effect of aflibercept on refractory macular edema associated with central retinal vein occlusion.阿柏西普对与视网膜中央静脉阻塞相关的难治性黄斑水肿的影响。

Can J Ophthalmol. 2017 Feb;52(1):137. doi: 10.1016/j.jcjo.2016.11.019. Epub 2017 Jan 5.

Baseline Choroidal Thickness as a Predictor for Treatment Outcomes in Central Retinal Vein Occlusion.基线脉络膜厚度作为视网膜中央静脉阻塞治疗结果的预测指标

Am J Ophthalmol. 2017 Apr;176:257-258. doi: 10.1016/j.ajo.2017.01.020. Epub 2017 Feb 9.

Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study.玻璃体内注射贝伐单抗治疗急性中央/半侧中央视网膜静脉阻塞：一项前瞻性临床研究的三年结果

J Ocul Pharmacol Ther. 2015 Mar;31(2):78-86. doi: 10.1089/jop.2014.0037. Epub 2014 Oct 14.

Ranibizumab in preproliferative (ischemic) central retinal vein occlusion: the rubeosis anti-VEGF (RAVE) trial.雷珠单抗治疗增殖前期（缺血性）视网膜中央静脉阻塞：抗新生血管性青光眼抗血管内皮生长因子（RAVE）试验

Retina. 2014 Sep;34(9):1728-35. doi: 10.1097/IAE.0000000000000191.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验